載入...
EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma
The EphA3 receptor has recently emerged as a functional tumour-specific therapeutic target in glioblastoma (GBM). EphA3 is significantly elevated in recurrent disease, is most highly expressed on glioma stem cells (GSCs), and has a functional role in maintaining self-renewal and tumourigenesis. An u...
Na minha lista:
| 發表在: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6316644/ https://ncbi.nlm.nih.gov/pubmed/30562956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers10120519 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|